CD26 expression is known to be increased in various immunomediated diseases, such as psoriasis and atopic dermatitis [89] Recently, it has been reported that the cutaneous expression of CD26 is also upregulated in BP patients, regardless of their previous gliptin exposure [88]. Here, DPP4 is linked to atopic eczema.